Graham Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,969
Closed -$414K 1137
2025
Q4
$414K Buy
+20,969
New +$377K 0.01% 706
2025
Q3
Sell
-181,644
Closed -$2.54M 1221
2025
Q2
$2.54M Buy
181,644
+152,738
+528% +$2.46M 0.04% 301
2025
Q1
$538K Buy
+28,906
New +$431K 0.01% 773
2023
Q3
Sell
-88,161
Closed -$507K 995
2023
Q2
$507K Buy
88,161
+55,073
+166% +$356K 0.01% 551
2023
Q1
$210K Sell
33,088
-172,736
-84% -$1.65M 0.01% 955
2022
Q4
$2.42M Buy
205,824
+58,818
+40% +$715K 0.07% 207
2022
Q3
$1.74M Buy
+147,006
New +$2.15M 0.07% 277
2022
Q1
Sell
-18,617
Closed -$261K 883
2021
Q4
$261K Buy
+18,617
New +$326K 0.01% 371

Other funds holding ALHC

Graham Capital Management's ALHC Position: Q1 2026 in Review

Graham Capital Management sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 20,969 shares — an estimated $414K sold.

Graham Capital Management first reported a position in ALHC in Q4 2021 and held it in 8 quarters. The position peaked at $2.54M in Q2 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Graham Capital Management reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 20,969 Alignment Healthcare shares in Q1 2026, an estimated $414K.
  • Graham Capital Management first reported a position in Alignment Healthcare in Q4 2021 and held it in 8 quarters.
  • Graham Capital Management's Alignment Healthcare position peaked at $2.54M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.